But weight loss in general, not just GLP-1-based weight loss, is often associated with some degree of muscle loss
Discussion Summary of findings In the present study, we found that the risk of MOF was slightly lower, albeit not significantly, in those treated with GLP-1 RA compared to those treated with DPP-4is as add-on therapies to metformin
The drug has a high bioavailability, so the efficacy is relatively rapid and long-lasting
And then well wrap up because this has been so valuable
A consultation gives you the chance to separate general awareness from personal medical guidance
Many patients taking GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Saxenda, Victoza) report feeling colder than usual during treatment